1038 related articles for article (PubMed ID: 10685665)
21. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE
J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324
[TBL] [Abstract][Full Text] [Related]
22. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells.
Irani DN; Lin KI; Griffin DE
J Immunol; 1996 Nov; 157(10):4333-40. PubMed ID: 8906807
[TBL] [Abstract][Full Text] [Related]
23. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
Whisler RL; Beiqing L; Chen M
Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
[TBL] [Abstract][Full Text] [Related]
24. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
[TBL] [Abstract][Full Text] [Related]
25. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
[TBL] [Abstract][Full Text] [Related]
26. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
27. Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Frankenberger B; Pohla H; Noessner E; Willimsky G; Papier B; Pezzutto A; Kopp J; Oberneder R; Blankenstein T; Schendel DJ
Clin Cancer Res; 2005 Mar; 11(5):1733-42. PubMed ID: 15755994
[TBL] [Abstract][Full Text] [Related]
28. [Tumor-immune system interaction in renal cell carcinoma and melanomas. Cytokine transcription in tumors at the time of surgical resection].
Zuber M; Filgueira L; Merlo A; Lüscher U; Juretic A; Spagnoli G; Harder F; Heberer M
Schweiz Med Wochenschr; 1994 Jun; 124(22):930-5. PubMed ID: 8029672
[TBL] [Abstract][Full Text] [Related]
29. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
31. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
Li J; Hu P; Khawli LA; Epstein AL
Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
[TBL] [Abstract][Full Text] [Related]
32. Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells.
Lederer JA; Liou JS; Kim S; Rice N; Lichtman AH
J Immunol; 1996 Jan; 156(1):56-63. PubMed ID: 8598494
[TBL] [Abstract][Full Text] [Related]
33. GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.
Das T; Sa G; Hilston C; Kudo D; Rayman P; Biswas K; Molto L; Bukowski R; Rini B; Finke JH; Tannenbaum C
Cancer Res; 2008 Mar; 68(6):2014-23. PubMed ID: 18339884
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
Gao X; Kuo J; Jiang H; Deeb D; Liu Y; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
Biochem Pharmacol; 2004 Jul; 68(1):51-61. PubMed ID: 15183117
[TBL] [Abstract][Full Text] [Related]
36. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
Wittmann M; Killig C; Bruder M; Gutzmer R; Werfel T
J Leukoc Biol; 2006 Jul; 80(1):75-86. PubMed ID: 16641133
[TBL] [Abstract][Full Text] [Related]
37. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function.
Bao JY; Huang Y; Wang F; Peng YP; Qiu YH
Neuroimmunomodulation; 2007; 14(6):344-53. PubMed ID: 18463421
[TBL] [Abstract][Full Text] [Related]
38. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
40. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
